Bioventix logo — Specializing in high-affinity sheep monoclonal antibodies fo...

Bioventix

Specializing in high-affinity sheep monoclonal antibodies for biotechnology advancements

Founded 2003 13 employees Biotechnology, Health Care

General Information

Company Name Bioventix
Founded Year 2003
Employees 13
Industries Biotechnology, Health Care
Social

Get notified when Bioventix moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Bioventix

Bioventix is a biotechnology startup specializing in the production of high-affinity sheep monoclonal antibodies (SMAs) for diagnostic applications, particularly in the field of clinical blood testing. Established in 2003, the company operates within the Biotechnology and Health Care sectors. Bioventix's unique focus on high-affinity SMAs positions it at the forefront of biotechnological advancements, offering innovative solutions for diagnostic and healthcare applications. The company's dedication to producing high-quality SMAs for biotechnology advancements is encapsulated in their slogan: "Specializing in high-affinity sheep monoclonal antibodies for biotechnology advancements." This strong positioning and specialized focus within the biotechnology sector demonstrate Bioventix's commitment to playing a pivotal role in advancing the field of diagnostic applications. While specific details about headquarters location and recent investments are not available at the moment, Bioventix's core focus on pioneering high-affinity SMAs for biotechnological and healthcare purposes positions them as a potential candidate for investment within the biotechnology sector. The innovative nature of their offerings and their positioning within the healthcare industry make Bioventix an intriguing entity for potential investment opportunities. In conclusion, Bioventix's commitment to manufacturing and supplying high-affinity SMAs for diagnostic applications showcases their dedication to advancing biotechnological and healthcare solutions. Although further details regarding recent investments and specific headquarters remain undisclosed, Bioventix's unique positioning within the biotechnology and healthcare sectors presents compelling prospects for potential investors.

Taxonomy: monoclonal antibodies, sheep antibodies, diagnostic applications, blood testing, biotechnology company, clinical testing, antibody creation, antibody supply, high affinity antibodies

No funding data available for Bioventix yet.

Get notified when Bioventix raises funding

Bioventix Alternatives & Competitors

Bioventix vs
Mabqi
Mabqi France

Your key partner for breakthrough antibody discovery

26 employees
Biotechnology
Bioventix vs

This is our old page and we no longer post updates here. For the latest news please follow Bio-Rad A...

63 employees
Biotechnology, Industrial
Bioventix vs

Your Leading Provider of Polyclonal Antibodies and Specialized Camelid Antibody Development!

12 employees
Biotechnology, Industrial

FAQ About Bioventix

Specializing in high-affinity sheep monoclonal antibodies for biotechnology advancements
Bioventix was founded in 2003.
Bioventix operates in the following industries: Biotechnology, Health Care.
Bioventix has approximately 13 employees.
Top alternatives and competitors to Bioventix include Mabqi, AbD Serotec - a Bio-Rad Company, Capralogics Inc, Macromoltek Inc., Abveris. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bioventix and Mabqi are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Bioventix and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy